Avita Medical | Zahlungsmittel Und Äquivalente



Cash And Equivalent Veränderung Datum
Adcock Ingram Holdings ZAR 79.14M 10.28M 2024-12
Celltrion KRW 829.07B 829.07B 2025-03
Clinuvel Pharmaceuticals AUD 35.2M 3.62M 2024-06
Cochlear AUD 383.1M 130.5M 2024-12
CSL 1.52B 133M 2024-12
Cspc Pharmaceutical 8.37B 3.64B 2024-06
Dianthus Therapeutics USD 22.79M 10.88M 2024-12
Divis Laboratories Ltd 4.15B 31.87B 2025-03
Kangmei Pharma CNY 894.14M 120.63M 2025-03
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 27.19M 17.39M 2024-12
Malin Corporation EUR 62.1M 26.4M 2024-12
Mayne Pharma 110.07M 838K 2024-06
Medical Developments International AUD 17.62M 7.88M 2024-12
Nanosonics AUD 4.84M 124.71M 2024-12
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Pacific Edge NZD 21.93M 7.33M 2024-09
Paradigm Biopharmaceuticals 17.82M 15.73M 2024-06
Pharma Mar EUR 60.29M 2.95M 2025-03
Polynovo 45.91M 330K 2024-06
PYC Therapeutics AUD 49.25M 17.62M 2024-12
Qiagen NV USD 638.76M 24.8M 2025-03
Ramsay Health Care AUD 341.1M 321.2M 2024-12
ResMed USD 521.94M 95.58M 2024-12
Sartorius EUR 839.5M 26.1M 2025-03
Sino Biopharmaceutical CNY 8.55B 902.41M 2024-06
Telix Pharmaceuticals 710.35M 587.11M 2024-12
Tilray USD 189.7M 15.49M 2024-11
Zz Pientze Pharmaceu 1.39B 93.82M 2025-03



Avita Medical Zahlungsmittel Und Äquivalente - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jun 2025.